Paras Healthcare IPO Allotment: How to Check Status and Understand GMP

Investors who applied for the recent Initial Public Offering (IPO) of Paras Healthcare are keenly awaiting their allotment status. The process of checking if shares have been allotted, and understanding the Grey Market Premium (GMP), are crucial steps for applicants.

It's important to note a point often discussed: while a recent NDTV Profit report mentioned interest in 'Jio Platforms, Paras Healthcare IPO Allotment', it is crucial for investors to understand that Jio Platforms, a subsidiary of Reliance Industries, has not yet undertaken a public IPO. Therefore, any discussions around its IPO allotment status are not applicable at this time. Our focus here will be on the verifiable process for IPOs like that of Paras Healthcare.

How to Check Paras Healthcare IPO Allotment Status

Once an IPO allotment is finalised, investors can typically check their application status through two primary official channels:

• Registrar's Website: The company appointed as the IPO registrar is responsible for managing the application and allotment process. For most IPOs, registrars are usually KFin Technologies or Link Intime India. You can visit their respective websites and select the 'IPO Allotment Status' section. You will then need to enter your PAN number, application number, or DP ID/Client ID to view your status.
• BSE Website: The Bombay Stock Exchange (BSE) also provides a facility to check IPO allotment status. Visit the BSE website, navigate to the 'Status of Issue Application' page, select the 'Equity' option, choose the IPO name (e.g., Paras Healthcare), and then enter your application number and PAN ID.

It is advisable to check the official website of the IPO registrar, which is usually mentioned in the prospectus, for the most accurate and timely information regarding the allotment.

Understanding Grey Market Premium (GMP)

The Grey Market Premium (GMP) refers to the unofficial price at which IPO shares trade in the grey market before their official listing on stock exchanges. It is an informal indicator of how investors anticipate the stock will perform on its listing day.

• Calculation: GMP is often expressed as a premium over the IPO's upper price band. For example, if an IPO is priced at ₹100 per share and its GMP is ₹20, it suggests the market expects the share to list around ₹120 (₹100 + ₹20).
• Speculative Nature: It is critical to understand that GMP is purely speculative and unofficial. It is not regulated by SEBI or any stock exchange. It can fluctuate significantly based on market sentiment, news, and overall economic conditions.
• Not a Guarantee: A high GMP does not guarantee a strong listing, nor does a low GMP signify a weak listing. The actual listing price can vary widely from the GMP indications. Investors should not base their investment decisions solely on GMP figures.

For retail investors, the GMP serves only as an indicative barometer of market sentiment. The decision to apply for an IPO should always be based on a thorough analysis of the company's fundamentals, financial health, management quality, and the industry outlook, rather than speculative grey market prices.

Applicants for Paras Healthcare IPO should keep an eye on official notifications from the registrar and stock exchanges for the final allotment status and listing date.

This article is for informational purposes only and does not constitute financial advice. Investors should conduct their own due diligence before making any investment decisions.